CKD Risk Factors for Didactic Presentation
For a comprehensive didactic presentation on CKD risk factors, organize content into non-modifiable and modifiable risk factors, with emphasis that modifiable factors—particularly hypertension, diabetes, and albuminuria—are the primary targets for preventing CKD progression and reducing cardiovascular mortality.
Non-Modifiable Risk Factors
These factors identify high-risk populations requiring intensified screening and monitoring:
- Age: Older adults have substantially higher CKD prevalence and absolute mortality risk, though relative risk from modifiable factors is paradoxically higher in younger patients 1
- Male sex: Men with CKD are 50% more likely than women to progress to end-stage kidney disease (ESKD) 2
- Race/ethnicity: Certain ethnic minorities, particularly Black and Hispanic populations, face higher CKD risk and faster progression 2
- Family history: Genetic predisposition to CKD, hypertension, or cardiovascular disease significantly increases risk 3, 4
- Low socioeconomic/educational status: Independently associated with higher CKD risk 3
Modifiable Risk Factors
Primary Drivers of CKD Development and Progression
Hypertension is the most critical modifiable risk factor, accounting for 34% of incident ESKD cases in the U.S. and affecting 72-90% of dialysis patients 3, 5. Blood pressure control is essential at all CKD stages 6, 7.
Diabetes mellitus causes diabetic kidney disease in 20-40% of patients with diabetes and is the leading cause of ESKD in the U.S. 6, 7. In type 1 diabetes, CKD typically develops after 10 years; in type 2 diabetes, it may be present at diagnosis 7.
Albuminuria (≥30 mg/g creatinine) is both a marker of kidney damage and an independent risk factor for CKD progression, cardiovascular disease, and mortality at all eGFR levels 6, 8. The degree of albuminuria directly correlates with progression risk 7.
Additional Modifiable Cardiovascular-Metabolic Risk Factors
Among U.S. adults with hypertension, multiple risk factors commonly coexist: 49.5% have obesity, 63.2% have hypercholesterolemia, 27.2% have diabetes, and 15.8% have CKD 3.
- Obesity/overweight: BMI ≥25 kg/m² (≥23 kg/m² for Asian ancestry) or abdominal obesity (waist circumference ≥88 cm women/≥102 cm men; ≥80/≥90 cm for Asian ancestry) 9
- Dyslipidemia: Elevated LDL cholesterol, triglycerides ≥150 mg/dL, low HDL cholesterol 3, 2
- Smoking: Current cigarette smoking and secondhand smoke exposure 3, 4
- Physical inactivity: Sedentary lifestyle and low fitness levels 3, 10
- Unhealthy diet: Particularly low plant-based food consumption and high ultraprocessed food intake 10
CKD-Specific Progression Risk Factors
Once CKD is established, these factors accelerate progression 6:
- Hyperglycemia: Poor glycemic control in diabetic patients
- Proteinuria: Higher levels predict faster progression 11
- Anemia: Lower hemoglobin associated with faster progression 11
- Metabolic acidosis: Common in advanced CKD stages
- CKD-mineral and bone disorders: Abnormal calcium, phosphate, PTH levels 6
- Acute kidney injury episodes: Each AKI event increases progressive CKD risk 6, 8
Risk Stratification Framework
Use the KDIGO CGA classification system (Cause, GFR category, Albuminuria category) to stratify patients into four risk levels 12, 10:
- Low risk: eGFR ≥60 mL/min/1.73 m² with albuminuria <3 mg/mmol
- Moderate risk: eGFR ≥60 with albuminuria 3-30 mg/mmol OR eGFR 45-59 with albuminuria <3 mg/mmol
- High risk: eGFR ≥60 with albuminuria >30 mg/mmol OR eGFR 45-59 with albuminuria 3-30 mg/mmol OR eGFR 30-44 with albuminuria <3 mg/mmol
- Very high risk: eGFR 30-44 with albuminuria ≥3 mg/mmol OR eGFR <30 at any albuminuria level
Clinical Implications for Screening
Screen patients with any of these high-risk conditions using both urine albumin-to-creatinine ratio and serum creatinine for eGFR calculation 4, 7:
- Diabetes (71% have hypertension) 3
- Hypertension
- Cardiovascular disease (34.2% prevalence in general population) 3
- Age ≥60 years (23.2% prevalence) 4
- Family history of kidney disease
- Obesity/metabolic syndrome
Common Pitfall to Avoid
Do not rely on serum creatinine alone—it is an unreliable marker of kidney dysfunction 13. Always calculate eGFR using validated equations (CKD-EPI preferred) and measure albuminuria, as reduced eGFR without albuminuria is increasingly common in both type 1 and type 2 diabetes 7, 8.
Key Teaching Points
The relationship between risk factors is complex and interdependent—they share common pathophysiologic mechanisms including renin-angiotensin-aldosterone system activation, sympathetic nervous system overactivity, endothelial dysfunction, and chronic inflammation 3, 5. Early identification through systematic screening of at-risk populations, combined with aggressive modification of treatable risk factors (especially blood pressure, glycemic control, and albuminuria reduction), can prevent or delay CKD progression and reduce the exceptionally high cardiovascular mortality in this population 4, 2, 13.